Provided herein are combinations of capsaicin and TrpV1 modulators that are useful for treating capsaicin-responsive diseases or disorders.

Compounds having a structure of Formula I ##STR00001##
or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.11a, R.sup.11b, R.sup.11c, R.sup.11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.

Compounds having a structure of Formula I ##STR00001##
or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.11a, R.sup.11b, R.sup.11c, R.sup.11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.

A method for producing a polyvalent alcohol ester compound, characterized in that a polyvalent alcohol compound and a carboxylic acid compound are allowed to react in the presence of an acidic solid catalyst swollen with the polyvalent alcohol compound or the carboxylic acid compound without using a solvent to selectively produce a monocarboxylic acid ester or a polycarboxylic acid ester of a polyvalent alcohol. In this manner, a mono-fatty acid ester and a poly-fatty acid ester (e.g., di-fatty acid ester) of a polyvalent alcohol can be selectively and effectively produced from a polyvalent alcohol compound and a fatty acid compound.

A method for producing a polyvalent alcohol ester compound, characterized in that a polyvalent alcohol compound and a carboxylic acid compound are allowed to react in the presence of an acidic solid catalyst swollen with the polyvalent alcohol compound or the carboxylic acid compound without using a solvent to selectively produce a monocarboxylic acid ester or a polycarboxylic acid ester of a polyvalent alcohol. In this manner, a mono-fatty acid ester and a poly-fatty acid ester (e.g., di-fatty acid ester) of a polyvalent alcohol can be selectively and effectively produced from a polyvalent alcohol compound and a fatty acid compound.

The present invention relates to the use of esters and/or ethers of 3-methyl-pentane-diol and unsaturated derivates thereof as aroma chemicals, to aroma chemical compositions comprising at least one ester of 3-methyl-pentan-diol and/or unsaturated derivates thereof and/or at least one ether of 3-methyl-pentan-diol and/or unsaturated derivates thereof and to a method for preparing an aroma chemical composition, in particular a fragranced composition, specifically a fragranced ready-to-use composition, which comprises incorporating at least one ester of 3-methyl-pentane-diol and/or one or more unsaturated derivates thereof and/or at least one ether 3-methyl-pentane-diol and/or one or more unsaturated derivates thereof into a composition, in particular into a ready-to-use composition. The present invention further relates to specific ethers of 3-methyl-pentane-diol and unsaturated derivates thereof and to specific esters of 3-methyl-pentane-diol, to specific mixtures of such compounds and to unsaturated derivates thereof and a method for their preparation.

The present invention relates to the use of esters and/or ethers of 3-methyl-pentane-diol and unsaturated derivates thereof as aroma chemicals, to aroma chemical compositions comprising at least one ester of 3-methyl-pentan-diol and/or unsaturated derivates thereof and/or at least one ether of 3-methyl-pentan-diol and/or unsaturated derivates thereof and to a method for preparing an aroma chemical composition, in particular a fragranced composition, specifically a fragranced ready-to-use composition, which comprises incorporating at least one ester of 3-methyl-pentane-diol and/or one or more unsaturated derivates thereof and/or at least one ether 3-methyl-pentane-diol and/or one or more unsaturated derivates thereof into a composition, in particular into a ready-to-use composition. The present invention further relates to specific ethers of 3-methyl-pentane-diol and unsaturated derivates thereof and to specific esters of 3-methyl-pentane-diol, to specific mixtures of such compounds and to unsaturated derivates thereof and a method for their preparation.

A method for producing diglycerides is provided. The method includes combining (i) an oil comprising at least one polyunsaturated fatty acid in the form of ethyl esters, free fatty acids, and/or combinations thereof, (ii) lipase, and (iii) glycerol in water to produce diglycerides with a high level of purity. Highly pure diglycerides obtained according to the method are also provided.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.